{"preliminary_commentary":{"by_channel":{"youtube":2,"podcast":2,"x_thread":2},"note":"Preliminary. Indexed podcasts, YouTube videos and X posts that name this trial so far. A report screens them, searches for more and cites what clinicians said when it is built, so final coverage is set at build."},"free_build":{"available":false},"name":"MesoVATS","nct_id":"NCT00821860","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=mesovats-nct00821860. The price is an estimate of verified statements from the commentary indexed so far, fixed at order. Final coverage is set when the report is built. We build the report within 24 hours of confirming the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_usd":750,"size":"focused","size_rule":"Focused: 1–150 verified statements, estimated at 14 per indexed commentary source"},"registry":{"acronym":"MesoVATS","arms":[{"description":"Patients undergo video-assisted thoracoscopic cytoreductive pleurectomy either at the time of biopsy or after confirmation of biopsy results.","label":"Arm I","type":"EXPERIMENTAL"},{"description":"Patients undergo talc pleurodesis via an indwelling intercostal chest drain or via thoracoscopy either at the time of biopsy or after confirmation of biopsy results.","label":"Arm II","type":"ACTIVE_COMPARATOR"}],"collaborators":[],"completion_date":{"date":"2013-05","type":"ACTUAL"},"conditions":["Malignant Mesothelioma","Metastatic Cancer"],"enrollment":{"count":196,"type":"ACTUAL"},"has_results":false,"interventions":[{"name":"talc","otherNames":[],"type":"OTHER"},{"name":"therapeutic thoracoscopy","otherNames":[],"type":"PROCEDURE"},{"name":"therapeutic videothoracoscopy","otherNames":[],"type":"PROCEDURE"}],"last_update":"2013-06-28","lead_sponsor":"Papworth Hospital NHS Foundation Trust","official_title":"Prospective Randomised Controlled Trial of Video-Assisted Thoracoscopic (VAT) Cytoreductive Pleurectomy Compared to Talc Pleurodesis in Patients With Suspected or Proven Malignant Mesothelioma","overall_status":"COMPLETED","phases":["PHASE3"],"primary_completion_date":{"date":"2013-02","type":"ACTUAL"},"primary_outcomes":[{"measure":"Survival at 1 year after treatment","timeFrame":"1 year"}],"references":[{"citation":"Rintoul RC, Ritchie AJ, Edwards JG, Waller DA, Coonar AS, Bennett M, Lovato E, Hughes V, Fox-Rushby JA, Sharples LD; MesoVATS Collaborators. Efficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): an open-label, randomised, controlled trial. Lancet. 2014 Sep 20;384(9948):1118-27. doi: 10.1016/S0140-6736(14)60418-9. Epub 2014 Jun 16.","pmid":"24942631","type":"DERIVED"}],"start_date":{"date":"2003-09"},"study_type":"INTERVENTIONAL","title":"Video-Assisted Surgery or Talc Pleurodesis in Treating Patients With Malignant Mesothelioma","url":"https://clinicaltrials.gov/study/NCT00821860"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"3.0","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/mesovats-nct00821860"}